Global Biochips Market to Reach US$ 64.3 Billion by 2032, Fostered by Increasing Prevalence of Chronic Disorders

April 25, 2023 | Healthcare

According to the latest report by IMARC Group, titled "Biochips Market Report by Product Type (DNA Chip, Protein Chip, Lab-On-a-Chip, Enzyme Chip), Fabrication Technique (Microarray, Microfluidic), Analysis Method (Electrophoresis, Luminescence, Mass Spectrometry, Electrical Signals, Magnetism), Application (Molecular Analysis, Diagnosis, Non-Biological Usage), End User (Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostics Centers, Academic and Research Institutes, and Others), and Region 2024-2032," the global biochips market size reached US$ 19.6 Billion in 2023. Biochips are miniaturized medical devices that are used in molecular laboratories to carry out several biochemical reactions simultaneously. They can rapidly screen a number of biological analytes for an array of applications, such as disease diagnosis and detection of hazardous biological agents in a system. They offer several advantages, including the ability to perform high-throughput analysis, allowing researchers to analyze thousands of samples in a short amount of time, and are also highly sensitive and specific, enabling the detection of low concentrations of biomolecules with high accuracy. They are utilized to determine gene expression, detect mutations, identify proteins, and screen for drug candidates. Consequently, they are used in a variety of applications, such as genomics, proteomics, and drug discovery. They can also be adopted in medical diagnostics, including detecting infectious diseases or cancer biomarkers. 

Global Biochips Market Trends:

The increasing prevalence of chronic disorders among the masses is driving the global market. Coupled with this, the growing consumer health concerns about several viral infections and immunological disorders are propelling the demand for biochips in new drug discovery and development activities. Moreover, the development of advanced biochip technologies, such as microfluidics and nanotechnology, has led to the creation of more sophisticated and efficient biochips that can perform a wide range of diagnostic and research applications, which is augmenting the market. Additionally, the increasing demand for non-invasive diagnostic tools is supporting the demand for biochips since they offer a non-invasive way to diagnose diseases, thereby reducing the risks and costs associated with invasive diagnostic procedures. Besides, the governments of several countries are heavily investing in biochip research and development to advance healthcare and life sciences research, which is creating a positive market outlook. The market is further driven by the widespread utilization of biochips in agriculture to analyze plant and soil samples, allowing for more precise and efficient farming practices. In line with this, the extensive adoption of biochips to monitor environmental conditions and detect pollutants in air, water, and soil is further strengthening the demand worldwide. Furthermore, the growing investments in the healthcare sector pertaining to cancer genomics, human proteome, and DNA analysis are impacting the market favorably. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 64.3 Billion by 2032, exhibiting a growth rate (CAGR) of 13.7% during 2024-2032. 

Market Summary:

  • On the basis of the product type, the market has been divided into DNA, protein, lab-on-a-, and enzyme chips.
  • Based on the fabrication technique, the market has been segmented into microarray and microfluidic.
  • On the basis of the analysis method, the market has been bifurcated into electrophoresis, luminescence, mass spectrometry, electrical signals, and magnetism.
  • Based on the application, the market has been classified into molecular analysis (hybridization, protein, immunological, biomolecules, biomarker, and others), diagnosis (gene diagnosis, oncology, inflammatory and others), and non-biological usage.
  • On the basis of the end user, the market has been categorized into pharmaceutical and biotechnology companies, hospitals and diagnostics centers, academic and research institutes, and others.
  • Based on the region, the market has been segregated into North America (United States, Canada), Europe (Germany, France, United Kingdom, Spain, Russia, Italy, and others), Asia Pacific (China, Japan, India, South Korea, Australia, and others), Latin America (Mexico, Brazil, Argentina, others), Middle East and Africa (Turkey, Saudi Arabia, the United Arab Emirates, and others).
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market. Some of the key players include Agilent Technologies, Inc., bioMérieux SA, Bio-RAD Laboratories, Inc., CapitalBio Corporation, Dynamic Biosensors GmbH, EMD Millipore Corporation, Fluidigm Corporation, Illumina, Inc., Perkinelmer, Inc., and Thermo Fisher Scientific Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Product Type, Fabrication Technique, Analysis Method, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Brazil, Mexico, Argentina, Turkey, Saudi Arabia, United Arab Emirates
Companies Covered Agilent Technologies, Inc., bioMérieux SA, Bio-RAD Laboratories, Inc., CapitalBio Corporation, Dynamic Biosensors GmbH, EMD Millipore Corporation, Fluidigm Corporation, Illumina, Inc., Perkinelmer, Inc., and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Biochips Market to Reach US$ 64.3 Billion by 2032, Fostered by Increasing Prevalence of Chronic Disorders
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More